Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial

NCT01746147 · clinicaltrials.gov ↗

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

MDS and AML Prior to Allogeneic SCT

Interventions

OTHER: No intervention and study treatment

Sponsor

GWT-TUD GmbH